Literature DB >> 26022180

Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling.

Hongzhao Li1, Aaron J Marshall2.   

Abstract

The ubiquitously expressed phosphoinositide 3-kinase (PI3K) family of lipid kinases control diverse cellular functions including cell survival, proliferation, metabolism and migration. Class I PI3Ks generate two distinct 3-phosphoinositide lipid messengers, PI(3,4,5)P3 (PIP3) and PI(3,4)P2, that recruit signaling effectors such as pleckstrin homology (PH) domain-containing proteins. Historically, the function of PI3K signaling has often been attributed to PIP3, with PI(3,4)P2 considered an inconsequential byproduct of PIP3 hydrolysis by SHIP phosphatases. However, accumulating evidence has demonstrated that PI(3,4)P2 directs a distinct branch of the PI3K pathway that regulates a variety of cellular processes with relevance to health and disease, such as B cell activation and autoantibody production, insulin sensitivity, neuronal dynamics, endocytosis and cell migration. Signaling through PI(3,4)P2 can be negatively regulated by inositol polyphosphate 4-phosphatases (INPP4A and INPP4B), which selectively degrade PI(3,4)P2. A number of signaling proteins that specifically bind to PI(3,4)P2 have been characterized, including the tandem PH domain-containing proteins (TAPP1 and TAPP2) and lamellipodin/RAPH1. A number of PIP3-binding proteins also bind to PI(3,4)P2, such as the protein kinase Akt/PKB, the most studied effector of PI3K signaling. Here, we review the current progress in understanding the functions and mechanisms of action of the PI(3,4)P2-specific phosphatases and binding proteins. A summary of available data addressing the relative contribution of PI(3,4)P2 versus PIP3 in regulation of Akt is provided to highlight the potential independent role of PI(3,4)P2 in regulating some PIP3-binding proteins. In summary, PI(3,4)P2-specific phosphatases and binding proteins are now firmly established players in cell biology, and this "neglected" phosphoinositide needs to take its place as one of the central components of the PI3K signaling pathway.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt/PKB; Chemotaxis; Cytoskeleton; Inositol phosphatase; Phosphatidylinositol 3,4 bisphosphate; Phosphoinositide 3-kinase

Mesh:

Substances:

Year:  2015        PMID: 26022180     DOI: 10.1016/j.cellsig.2015.05.013

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  43 in total

Review 1.  Phosphoinositides: multipurpose cellular lipids with emerging roles in cell death.

Authors:  Thanh Kha Phan; Scott A Williams; Guneet K Bindra; Fung T Lay; Ivan K H Poon; Mark D Hulett
Journal:  Cell Death Differ       Date:  2019-02-11       Impact factor: 15.828

Review 2.  Profilin: many facets of a small protein.

Authors:  Rhonda J Davey; Pierre Dj Moens
Journal:  Biophys Rev       Date:  2020-07-13

Review 3.  Polyphosphoinositide-Binding Domains: Insights from Peripheral Membrane and Lipid-Transfer Proteins.

Authors:  Joshua G Pemberton; Tamas Balla
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 4.  Tied up: Does altering phosphoinositide-mediated membrane trafficking influence neurodegenerative disease phenotypes?

Authors:  Sravanthi S P Nadiminti; Madhushree Kamak; Sandhya P Koushika
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 5.  The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.

Authors:  Ana Raquel Ramos; Somadri Ghosh; Christophe Erneux
Journal:  J Lipid Res       Date:  2018-09-07       Impact factor: 5.922

6.  A direct fluorometric activity assay for lipid kinases and phosphatases.

Authors:  Jiachen Sun; Indira Singaram; Mona Hoseini Soflaee; Wonhwa Cho
Journal:  J Lipid Res       Date:  2020-04-27       Impact factor: 5.922

7.  Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response.

Authors:  Colin T Shearn; Blair Fennimore; David J Orlicky; Yue R Gao; Laura M Saba; Kayla D Battista; Stefanos Aivazidis; Mohammed Assiri; Peter S Harris; Cole Michel; Gary F Merrill; Edward E Schmidt; Sean P Colgan; Dennis R Petersen
Journal:  Free Radic Biol Med       Date:  2019-08-01       Impact factor: 7.376

Review 8.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

9.  PI3K activation within ventromedial prefrontal cortex regulates the expression of drug-seeking in two rodent species.

Authors:  Karen K Szumlinski; Alexis W Ary; Christina B Shin; Melissa G Wroten; Justin Courson; Bailey W Miller; Micaela Ruppert-Majer; John W Hiller; John R Shahin; Osnat Ben-Shahar; Tod E Kippin
Journal:  Addict Biol       Date:  2018-11-18       Impact factor: 4.280

10.  INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia.

Authors:  Ping Wang; Dan Ma; Jishi Wang; Qin Fang; Rui Gao; Weibing Wu; Lu Cao; Xiuying Hu; Jiangyuan Zhao; Yan Li
Journal:  Tumour Biol       Date:  2016-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.